What’s Trending?

The pathway is a programme designed to develop pharmacists' knowledge of mental health among patients [...]
Wed, Feb 08, 2023
Source PharmaTimes
The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere [...]
Wed, Feb 08, 2023
Source PharmaTimes
Researchers from Charité - Universitätsmedizin Berlin, the Max Planck Institute for Molecular Genetics (MPIMG), and the University Hospital Schleswig-Holstein (UKSH) have investigated in detail how BPTA syndrome, an extremely rare hereditary condition, arises. A change in the charge of a protein disrupts cellular self-organization, resulting in a developmental disorder. [...]
Wed, Feb 08, 2023
Source WorldPharmaNews
Financing will allow company's development of DNA synthesis chip technology to commercial scale [...]
Tue, Feb 07, 2023
Source PharmaTimes
Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure [...]
Tue, Feb 07, 2023
Source PharmaTimes
Bayer
The Bayer Foundation has presented the Otto Bayer Award, complete with its prize money of 75,000 euros, to Professor Frank Glorius. The research scientist at the University of Münster received the award in recognition of the development of an extensive array of groundbreaking catalytic reactions for organic synthesis, facilitating the [...]
Tue, Feb 07, 2023
Source WorldPharmaNews
The viruses Kaposi sarcoma-associated herpesvirus (KSHV) and Epstein-Barr virus (EBV) have been linked to several cancers. For the first time, UNC School of Medicine scientists have discovered that these viruses use a human protein called barrier-to-autointegration factor 1, or BAF, to evade our innate immune response, allowing the viruses to [...]
Mon, Feb 06, 2023
Source WorldPharmaNews
A new way to significantly increase the potency of almost any vaccine has been developed by researchers from the International Institute for Nanotechnology (IIN) at Northwestern University. The scientists used chemistry and nanotechnology to change the structural location of adjuvants and antigens on and within a nanoscale vaccine, greatly increasing [...]
Fri, Feb 03, 2023
Source WorldPharmaNews
Sponsors submitting pediatric study plans should consider whether a product affects adults and children similarly when choosing an approach, the FDA says. [...]
Fri, Jan 16, 2015
Source FDANews